Evidence map›Paper›PMID 39904863›Full record

ArticleThe AAPS journal2025

Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice Chairs.

Kristy M Ainslie, Albert A Bowers, Robert H Chichewicz, Lara S Collier, Jonathan A Doorn, Christopher R Frei, Hamidreza Ghandehari, Robert B Gibbs, David S Lawrence, Craig R Lee and 10 more

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kristy M AinslieDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. ainsliek@email.unc.edu.ORCID 0000-0002-1820-8382
Albert A BowersDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Robert H ChichewiczMedicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Lara S CollierPharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
Jonathan A DoornDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA.
Christopher R FreiCollege of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
Hamidreza GhandehariDepartments of Molecular Pharmaceutics and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Robert B GibbsDepartment of Pharmaceutical Sciences, University of Pittsburgh, 1004 Salk Hall, Pittsburgh, Pennsylvania, USA.
David S LawrenceDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Craig R LeeDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Donald E MagerDepartment of Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, New York, USA.
Paul MarkerPharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
Anna SchwendemanDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Raj SuryanarayananDepartment of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Robert O WilliamsCollege of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery, The University of Texas at Austin, Austin, TX, USA.
Yaguang XiDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, USA.
Wen XieDepartment of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Xiang-Qun XieDepartment of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Guizhi ZhuDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Juliane NguyenDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. julianen@email.unc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On October 29, 2024, a virtual meeting, brought together chairs and vice chairs from several research-oriented U.S. Schools of Pharmacy to discuss the current landscape of pharmaceutical sciences, advocacy strategies, and best practices in graduate education. Key topics included alumni engagement, and the relatively low number of trainees interested in an academic career path. Dr. Dawn Beraud, the Executive Director of the American Institute for Medical and Biological Engineering (AIMBE) emphasized the importance of science advocacy, including increasing science funding and linking evidence-based decision making to policy. Discussions about graduate education highlighted best practices in using large language models, financial support challenges, and the significant role of industrial professionals in teaching. The proposed NextProf PharmSci program was discussed, which aims to address the imbalance of trainees leaning towards industry by preparing them for academic roles through a multi-day workshop. Participants expressed strong support for this initiative, emphasizing the need for a training pipeline and mentoring junior faculty. Participants agreed the event should be held annually, as it was found to be useful, and discussed future topics including sharing graduate and PharmD curricula as well as a shared summer school program.

Indexed as

Education, Pharmacy, GraduateCurriculumHumansSchools, PharmacyUnited Statesalumnichatbotsgraduate education

Identifiers

PMID39904863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.